RAFAEL HOLDINGS, INC. Deferred Tax Assets, Operating Loss Carryforwards, Domestic
RAFAEL HOLDINGS, INC. (RFL) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $63.20 million as of 2023-07-31, per its 10-K filed 2023-10-30.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2023-10-30
- 2023-07-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $63.20M.
- 2022-07-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $54.90M.
- 2021-07-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $47.00M.
- 2021-04-30: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $44.00M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic |
|---|---|
| 2023-07-31 | $63.20M 10-K · filed 2023-10-30 |
| 2022-07-31 | $54.90M 10-K · filed 2022-10-31 |
| 2021-07-31 | $47.00M 10-K · filed 2021-10-18 |
| 2021-04-30 | $44.00M 10-Q · filed 2021-06-14 |
| 2021-01-31 | $41.70M 10-Q · filed 2021-03-17 |
| 2020-10-31 | $34.40M 10-Q · filed 2020-12-15 |
| 2020-07-31 | $13.60M 10-K · filed 2020-10-29 |
| 2019-07-31 | $3.20M 10-Q · filed 2020-06-09 |
| 2019-04-30 | $1.50M 10-Q · filed 2019-06-05 |
| 2019-01-31 | $610.00K 10-Q · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |